News & Announcements

SafeScript NSW’s new approval management functionality will mean that prescribers (medical, nurse and dental practitioners) will be able to apply online for approval to prescribe or supply certain Schedule 8 medicines (in some cases, be issued approvals in real time), monitor application progress, view patient approval (previously referred to as an authority) history, have visibility of the number of active approvals held and see all approvals held within their organisations.

The aim of the study is to describe the levels of knowledge, attitudes and current practice (KAP) amongst general practitioners (GPs) and practice nurses (PNs) working in general practice, as well as community pharmacists (CPs) regarding long acting reversible contraception (LARC) and early medical abortion (EMA).

Primary care providers and their staff are increasingly finding themselves as part of the front line dealing with the impact of disasters.

Over recent years the Hunter New England and Central Coast regions experienced the effects of the COVID-19 pandemic, bushfires, drought, extreme weather events including thunderstorms and severe floods, and a rodent plague.

From 1 July 2023, ODT medicines will become part of the Section 100 Highly Specialised Drugs (HSD) Program (Community Access) arrangements. This means ODT medicines will be dispensed in the same way as other community access Section 100 HSD Program medicines from section 90 approved community pharmacies, section 92 approved medical practitioners, and section 94 approved hospital authorities (public and private).

With Heart week starting on Monday May 3 the PHN’s rural Clinical Council is urging all health professionals and community members to start a conversation about heart health and discuss the steps we all need to take to reduce our risk of developing heart disease.